BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35965785)

  • 1. The m
    Guo S; Zhao C; Fang L; Xu W; Dalia S; Glass J; Shikama N; Zhang Z
    Ann Transl Med; 2022 Jul; 10(14):779. PubMed ID: 35965785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90.
    Kuai Y; Gong X; Ding L; Li F; Lei L; Gong Y; Liu Q; Tan H; Zhang X; Liu D; Ren G; Pan H; Shi Y; Berberich-Siebelt F; Mao Z; Zhou R
    Cell Commun Signal; 2018 Aug; 16(1):50. PubMed ID: 30143009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
    Cheng Y; Fu Y; Wang Y; Wang J
    Front Genet; 2020; 11():955. PubMed ID: 33061938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.
    Han H; Fan G; Song S; Jiang Y; Qian C; Zhang W; Su Q; Xue X; Zhuang W; Li B
    Blood; 2021 Mar; 137(12):1603-1614. PubMed ID: 32967010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP.
    He L; Chen S; Ying Y; Xie H; Li J; Ma X; Wang W; Shen H; Wang X; Zheng X; Xie L
    Cancer Med; 2021 Oct; 10(20):7222-7232. PubMed ID: 34595849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
    Feng L; Yan Q; Pan H; Shi W
    Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
    Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
    Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice.
    Li X; Yang Y; Li Z; Wang Y; Qiao J; Chen Z
    Diabetologia; 2023 Jun; 66(6):1084-1096. PubMed ID: 36920524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Regulatory Effect of RNA m
    Li YQ; Shao YL; Li MY; Wang LL; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):382-388. PubMed ID: 38660840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2.
    Kong Y; Wu R; Zhang S; Zhao M; Wu H; Lu Q; Fu S; Su Y
    Int Immunopharmacol; 2020 Nov; 88():106918. PubMed ID: 32866786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m
    Luo Q; Zhan X; Kuang Y; Sun M; Dong F; Sun E; Chen B
    Med Oncol; 2022 Sep; 39(12):231. PubMed ID: 36175708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
    Liu N; Zhang C; Zhang L
    Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37477820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
    Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.
    Xie F; Zhu X; Liu X; Chen H; Wang J
    J Biol Chem; 2022 Dec; 298(12):102715. PubMed ID: 36403857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
    Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
    J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.